[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351723-105":59,"doc-detail-351723-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","incidence-and-management-trends-in-advanced-head-and-neck-non-melanoma-skin-cancer-in-ontario","Incidence and Management Trends in Advanced Head and Neck Non-Melanoma Skin Cancer in Ontario","","Head and neck non-melanoma skin cancers (H&N NMSCs) constitute most malignancies in the head and neck region, where surgery is standard and adjuvant radiation is recommended for advanced tumors. A longitudinal, population-based analysis using Ontario ICES data from 2003–2019 assessed incidence, survival, and radiation utilization after resection for locally advanced (rLA) and locoregional (rLR) disease. Despite rLA incidence rising more than tenfold versus population growth, radiation oncology consultations occurred in only 29.6% (rLA) and 50.7% (rLR) and adjuvant RT was delivered to 19.4% and 37.95%, respectively.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/incidence-and-management-trends-in-advanced-head-and-neck-non-melanoma-skin-cancer-in-ontario/351723/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/incidence-and-management-trends-in-advanced-head-and-neck-non-melanoma-skin-cancer-in-ontario/351723.png","ImageObject",300,407,{"name":92,"@type":93},"McQueen","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s main purpose in Ontario?","Question",{"text":112,"@type":113},"To characterize disease incidence, survival outcomes, and radiation utilization patterns for resected locally advanced and locoregional head and neck non-melanoma skin cancers from 2003 to 2019.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did incidence trends differ between locally advanced and locoregional disease?",{"text":117,"@type":113},"Locally advanced (rLA) incidence increased more than tenfold compared with population growth, while locoregional (rLR) incidence remained stable.",{"name":119,"@type":110,"acceptedAnswer":120},"How often did patients receive radiation after consultation and surgery?",{"text":121,"@type":113},"Radiation oncology consultations occurred in 29.6% of rLA and 50.7% of rLR patients; adjuvant radiation was received by only 19.4% of rLA and 37.95% of rLR disease.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351723,1790101611,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Article  \nIncidence and Management Trends in Advanced Head and Neck Non-Melanoma Skin Cancer in Ontario  \nKa-Kit David Yeung 1, Gregory Pond 1, Isaac Kong 1, Han Zhang 2, Michael Gupta 2, Zejia Chen 3 and Justin Lee 1, *  \nReceived: 28 March 2026  \nRevised: 7 May 2026  \nAccepted: 14 May 2026  \nPublished: 17 May 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Division of Radiation Oncology, Department of Oncology, Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada  \n2 Division of Otolaryngology, Department of Surgery, Faculty of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada  \n3 Faculty of Medicine, Queen’s University, Kingston, ON K7L 3N6, Canada  \n* Correspondence: [leejus@hhsc.ca](leejus@hhsc.ca)  \nSimple Summary  \nNon-melanoma head and neck skin cancers are the most common cancers in the head and neck region. For people with advanced or more widespread disease, the American Society of Radiation Oncology has published guidelines that recommends surgery to be followed by radiation to lower the risk of cancer recurrence. However, it is unclear how often patients are referred to a radiation oncologist or receive this treatment. Using Ontario health data from 2003 to 2019, this study included more than 4000 patients with these cancers to characterize disease rates and identify factors influencing radiation referral and treatment. The number of patients with advanced disease grew over tenfold faster than population growth, but only 35% of those with locally advanced or nodal disease had a consultation with a radiation specialist. These findings highlight a need to understand why referrals and utilization are low and may inform the implementation of care pathways and local guidelines.  \nAbstract  \nHead and neck non-melanoma skin cancers (H&N NMSCs) account for most head and neck malignancies. While primary treatment comprises surgery, adjuvant radiation is recommended in advanced tumors. Radiation oncology practice patterns for resected locally advanced (rLA) and locoregional (rLR) H&N NMSCs have not been well characterized. Using data from the Institute for Clinical Evaluative Sciences (ICES) between 2003 and 2019, we conducted a longitudinal, population-based study characterizing disease incidence, survival outcomes, and radiation utilization patterns. Among 2962 rLA and 1055 rLR cases, rLA incidence rose more than tenfold compared to population growth; however rLR incidence remained stable. Radiation oncology consultations occurred in 29.6% of rLA and 50.7% of rLR patients. Increased age, multiple cancers at diagnosis, non-rural demographic, and higher SES were observed to be correlated to receipt of adjuvant radiation treatment. Only 19.4% of rLA and 37.95 of rLR disease received adjuvant RT, which is much lower than expected based on international guidelines. Five-year overall survival (OS) was 69%(95% confidence interval (CI): 67–71%) for rLA and 68%(95% CI: 65–71%) for rLR disease. These findings highlight the burden of advanced H&N NMSC, low rates of radiation utilization and the need for improving referral pathways and guideline adherence.  \nKeywords: head and neck cancer; non-melanoma skin cancer; adjuvant radiation; radiation oncology; adjuvant treatment; population-based study; Canada; Ontario  \n1. Introduction  \nNon-melanoma skin cancers (NMSCs) are the most prevalent type of cancer in North America, making up 28% of new cancer cases in Canada with an estimated 36% increase in incidence since the 2000s [1–3] . Over 77% of these cases are basal cell carcinomas (BCCs), with the remaining 23% being squamous cell carcinomas (SCCs) [4–6] . Of these, 80% of cases occur in the head and neck area, classified as head and neck non-melanoma skin cancers (H&N NMSCs) [7–13] .  \nMost patients have early-stage disease with","cbCaigQLuxl0t47p","https://ap.wps.com/l/cbCaigQLuxl0t47p","pdf",1077598,17,"English","# Introduction\n## Epidemiology and burden of head and neck NMSCs\n## Clinical rationale for adjuvant radiation\n## Study rationale and research aims","[{\"question\":\"What was the study’s main purpose in Ontario?\",\"answer\":\"To characterize disease incidence, survival outcomes, and radiation utilization patterns for resected locally advanced and locoregional head and neck non-melanoma skin cancers from 2003 to 2019.\"},{\"question\":\"How did incidence trends differ between locally advanced and locoregional disease?\",\"answer\":\"Locally advanced (rLA) incidence increased more than tenfold compared with population growth, while locoregional (rLR) incidence remained stable.\"},{\"question\":\"How often did patients receive radiation after consultation and surgery?\",\"answer\":\"Radiation oncology consultations occurred in 29.6% of rLA and 50.7% of rLR patients; adjuvant radiation was received by only 19.4% of rLA and 37.95% of rLR disease.\"}]","Incidence and Management Trends in Advanced Head and Neck Non-Melanoma Skin Cancer in Ontario | PDF",1790095524,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bfa784b81a9eff868d9ce6d17cd1dc19.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80338e20772345b3bdbedc08ec5de820.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f382ab35c11eb83c96f79dac51a951b3.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2813b7d5866a3dd2cd3f9d4064a5479c.webp",980,1385]